Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06772701

Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father

In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. Investigators now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period.

The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers.

They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Antoine-Béclère hospital AP-HP, Clamart, France

Loading trial locations.

About this study

Fathers complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All fathers whose baby is 10 days old or less

Exclusion criteria

  • People with a poor understanding of spoken or written French
  • Minors
  • Persons under court protection, guardianship or curatorship

Treatment and study plan

Mini International Neuropsychiatric Interview

Diagnostic Test

Fathers have Mini International Neuropsychiatric Interview, the standard diagnostic tool for post-natal depression

EPDS book

Other

PH-Q9, EPDS and socio-demographic questionnaires are completed online at inclusion and 6 to 8 weeks after the birth of child.

Primary outcomes

  1. Mini International Neuropsychiatric Interview

    Time frame: at inclusion

    This short structured clinical interview is used to diagnose psychiatric disorders and is currently the gold standard for diagnosing depression.

Secondary outcomes

  1. socio-demographic questionnaire

    Time frame: at inclusion and 6 to 8 weeks after the birth of their child

    Socio-demographic data will be a secondary evaluation criterion. It will be used to study risk and protective factors, both those already known in the literature and those that have been little studied, and to identify profiles that are more at risk, with a view to taking preventive action in the field.

Study contacts

Contact information is provided by the study sponsor or research team.

Angélique PICARD, project coordinator

CONTACT

[email protected]

+33232734856

Christophe FRUIT, CRA

CONTACT

[email protected]

+33232734857

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier du Havre

Other

Registry information

Acronym: EPDS-PERE

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jan 13, 2025
Registry last updated
Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.